Levosimendan is a new type of drug that helps to improve the function of the heart. Small studies had showed some promising results in relation to the use of this drug in patients with sepsis. This large double blind study however, did not show any improvement in organ function and increased survival rate for those that received the active drug. 

For the full results of this study visit The New England Journal of Medicine for the published article.